Meiji Yasuda Asset Management CO Ltd. Bio Rad Laboratories, Inc. Transaction History
Meiji Yasuda Asset Management CO Ltd.
- $2.57 Billion
- Q3 2024
A detailed history of Meiji Yasuda Asset Management CO Ltd. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Meiji Yasuda Asset Management CO Ltd. holds 761 shares of BIO stock, worth $249,204. This represents 0.01% of its overall portfolio holdings.
Number of Shares
761Holding current value
$249,204% of portfolio
0.01%Shares
8 transactions
Others Institutions Holding BIO
# of Institutions
456Shares Held
18.2MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.91MShares$625 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$508 Million0.01% of portfolio
-
Van Eck Associates Corp1.3MShares$427 Million0.55% of portfolio
-
Veritas Asset Management LLP1.09MShares$356 Million3.03% of portfolio
-
First Eagle Investment Management, LLC713KShares$233 Million0.5% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.07B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...